Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Future antibiotic trials.

P Ball1

  • 1School of Biomedical Sciences, University of St. Andrews, Fife, Scotland.

Seminars in Respiratory Infections
|April 5, 2000
PubMed
Summary
This summary is machine-generated.

Antibiotics offer limited benefit for mild chronic bronchitis exacerbations, potentially increasing bacterial resistance. Further research is needed to confirm benefits in severe cases and explore alternative outcome measures for effective therapy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Performance of Sri Lankan FRAX algorithm without bone mineral density and with Quantitative Ultrasound data input

The Ceylon medical journal·2019
Same author

Estrogen responsiveness of progestin receptor induction in the pituitary, preoptic-hypothalamic brain and uterus of neonatally estrogenized female rats.

Brain research·2013
Same author

Reliability of hindfoot goniometry when using a flexible electrogoniometer.

Clinical biomechanics (Bristol, Avon)·2013
Same author

U.N.R.R.A. brings health and hope to the victims of total war.

Modern hospital·2010
Same author

Developing sustainable models of rural health care: a community development approach.

Rural and remote health·2007
Same author

Circadian function in patients with advanced non-small-cell lung cancer.

British journal of cancer·2005
Same journal

TB vaccines at the turn of the century: insights into immunity to M. tuberculosis and modern approaches for prevention of an ancient disease.

Seminars in respiratory infections·2003
Same journal

Environmental infection control of tuberculosis.

Seminars in respiratory infections·2003
Same journal

Mycobacterium tuberculosis: the treatment of active disease.

Seminars in respiratory infections·2003
Same journal

Pediatric tuberculosis.

Seminars in respiratory infections·2003
Same journal

Clinical and radiographic features of HIV-related tuberculosis.

Seminars in respiratory infections·2003
Same journal

Treatment of latent tuberculosis infection.

Seminars in respiratory infections·2003
See all related articles

Area of Science:

  • Pulmonology
  • Infectious Diseases
  • Pharmacology

Background:

  • The efficacy of antibiotic treatment for acute exacerbations of chronic bronchitis (AECB) is debated.
  • While short-term benefits are acknowledged, widespread antibiotic use, especially for mild exacerbations, is questioned.
  • Over-prescription may contribute to the growing problem of bacterial resistance.

Purpose of the Study:

  • To critically evaluate the established and potential benefits of antibiotic therapy in AECB.
  • To explore the necessity of designing new clinical trials for severe AECB to validate antibiotic efficacy.
  • To investigate alternative outcome measures beyond traditional bacteriological and short-term clinical assessments.

Main Methods:

  • Review of existing literature and clinical trial data on antibiotic use in AECB.

Related Experiment Videos

  • Analysis of the relationship between prescription volume and evidence of benefit in mild exacerbations.
  • Discussion of the need for novel trial designs focusing on both short- and longer-term patient outcomes.
  • Consideration of quality of life and symptom-free intervals as relevant endpoints.

    • Main Results:

    • Evidence supporting antibiotic use in mild AECB is scarce, suggesting many prescriptions are unnecessary.
    • Most therapeutic episodes for mild exacerbations likely do not provide significant benefit and may promote antibiotic resistance.
    • There is a lack of robust data validating the benefits of novel or existing antibiotics in severe AECB.
    • Current assessment methods may not adequately capture the true impact of antibiotic interventions.

    Conclusions:

    • Antibiotic use in mild AECB is likely overutilized and offers minimal proven benefit, contributing to resistance.
    • Further research with rigorous trial designs is essential to determine the true value of antibiotics in severe AECB.
    • Exploring alternative outcome measures like quality of life and long-term symptom control is crucial for optimizing therapy.
    • A deeper understanding of bacterial involvement in chronic bronchitis is needed for developing more effective treatments.